Virginia Tech® home

Home

Insert your title here

 

Featured Story

May 19, 2023

Cancer researchers team up against deadliest brain tumors in children

Virginia Tech researchers with the Fralin Biomedical Research Institute at VTC have joined a Children’s National Hospital effort to treat deadly brain tumors with ultrahigh frequency sound waves. The scientists are studying how to use an emerging technology called focused ultrasound to fight diffuse midline glioma (DMG), one of the most lethal childhood brain cancers with a nearly 100 percent rate of mortality within five years of diagnosis.

Creating a healthier future. For everyone.

The Fralin Biomedical Research Institute at VTC is one of the nation’s fastest-growing academic biomedical research enterprises and a destination for world-class researchers. The institute’s Virginia Tech scientists focus on diseases that are the leading causes of death and suffering in the United States, including brain disorders, heart disease, and cancer. Since its founding in 2010, the research institute has experienced unprecedented growth: doubling its enterprise and lab facilities in Roanoke, while also investing in brand-new laboratories on the Children’s National Research & Innovation Campus in Washington, D.C.

Loading player for https://video.vt.edu/media/Welcome+to+the+Fralin+Biomedical+Research+Institute/1_7bgzxc60...


VIDEOS
 

Loading player for https://www.youtube.com/watch?v=_RXG3fUC2BU&feature=emb_title...

Giving to the Research Institute

Your generous support of the Fralin Biomedical Research Institute's rigorous biomedical research enterprise makes a difference for our faculty, students, and patients. Every donation helps accelerate the pace of new discoveries to help patients with cancer, neurological disorders, heart disease, and even rare genetic disorders. Private donations fast-track our progress.